Mealey's (August 22, 2019, 12:49 PM EDT) -- NEW ORLEANS — A Louisiana federal judge who will preside over the first Taxotere multidistrict litigation hair loss bellwether trial on Aug. 14 denied preemption summary judgment to defendant Sanofi-Aventis, saying the manufacturer’s regulatory submissions to the Food and Drug Administration aren’t “clear evidence” that the agency rejected a stronger label warning about permanent hair loss from the breast cancer drug (In Re: Taxotere [Docetaxel] Products Liability Litigation, [Barbara Earnest v. Sanofi-Aventis, No. 16-17144], MDL Docket No. 2740, No. 16-md-2740, E.D. La.)....